Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Posted on by Pencis

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Zhejiang Provincial Center for Disease Control and Prevention | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Huakun Lv earned his Master of Science in Epidemiology and Health Statistics from the School of Public Health, Southeast University, Nanjing, in 2005. Prior to that, he completed his Bachelor of Science in Preventive Medicine at the same institution in 1992. His academic journey laid a strong foundation in public health, epidemiology, and disease prevention, equipping him with the expertise to address complex health challenges and lead immunization initiatives.

💼PROFESSIONAL ENDEAVORS

Dr. Lv, Chief Physician and Director of the Immunization Program at Zhejiang CDC, has been a driving force in vaccine strategies, coverage, and disease prevention since 2014. Previously, as Deputy Director of Infectious Disease Control and Prevention (2005–2014), he played a pivotal role in infectious disease surveillance, building on his frontline public health experience at Danyang CDC, Jiangsu Province (1992–2002). Beyond his institutional leadership, he has made significant global health contributions, serving as an Epidemiologist in the Chinese Government Emergency Medical Team in the Philippines (2013) during the Typhoon Haiyan response and as Deputy Director of the Zhejiang Public Health and Medical Team in Qingchuan, Sichuan Province (2008) after the Sichuan Earthquake. His expertise in applied epidemiology was further strengthened as a Visiting Scholar at Emory University’s School of Public Health (2011).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASE VACCINES

Dr. Lv’s research primarily focuses on epidemiology and the prevention of vaccine-preventable diseases. His work encompasses immunization program policies, the effectiveness of vaccination strategies, and the epidemiology and virology of Hand, Foot, and Mouth Disease (HFMD). He has also conducted significant studies on biofilm resistance and endoscopic disinfection practices, contributing to the broader understanding of infection control. His involvement in vaccine clinical trials and public health interventions has played a crucial role in shaping vaccine policies and improving disease prevention measures.

🌍IMPACT AND INFLUENCE

Dr. Lv’s impact on public health extends beyond Zhejiang Province, as he has been at the forefront of immunization initiatives that have improved vaccine accessibility and effectiveness. His expertise in epidemiology has led to substantial contributions in global disease control efforts. His involvement in emergency medical responses and his advisory roles in infectious disease management have positioned him as a key figure in international public health collaborations.

📚ACADEMIC CITATIONS

Dr. Lv’s research has been widely recognized and cited in scientific publications. Notable among his achievements is his study on the Epidemiological and Etiological Characteristics of HFMD in Zhejiang Province, which earned him a Second Prize Award. Additionally, his research on the Effect of Endoscopic Cleaning and Disinfection on Biofilm received a Third Prize Award. His publications have contributed significantly to the understanding of infectious disease epidemiology and vaccine effectiveness, influencing public health policies and practices.

🏆RESEARCH GRANTS AND FUNDING

Dr. Lv has successfully secured multiple research grants for immunization and epidemiology projects. His funding contributions have supported vaccine clinical trials, public health surveillance initiatives, and innovative disease prevention strategies. These grants have facilitated critical research aimed at enhancing vaccination programs and improving disease control efforts at both national and international levels.

🦠LEGACY AND FUTURE CONTRIBUTIONS

With a commitment to mentoring the next generation of epidemiologists and public health professionals, Dr. Lv continues to play an active role in academia and research. His dedication to advancing vaccine research, implementing effective immunization policies, and fostering global collaborations in infectious disease prevention underscores his lasting impact on public health. His vision is to continue developing innovative strategies that address emerging infectious diseases and strengthen global health security.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lv holds several prestigious positions in professional organizations. He serves as Vice-Chairman of the Division of Immunology at the Zhejiang Preventive Association and is a Master Supervisor at the School of Public Health, Xiamen University. He is also a Field Tutor for the Chinese Field Epidemiology Training Program (CFETP) at the Chinese CDC and a Research Supervisor at the Chinese Hepatitis Prevention and Treatment Foundation. Additionally, he is a Standing Committee Member of the Division of Vaccine Clinical Trials at the China Association for Vaccines (CAV). His leadership in these roles reflects his commitment to advancing infectious disease research, vaccine development, and public health policy.

📑NOTABLE PUBLICATIONS

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens

Authors: H. Lv, Huakun; X. Chen, Xu; B. Xing, Bo; Z. Liang, Zhenzhen; Y. Mao, Yu
Year: 2025
Journal: Scientific Reports

Immunogenicity and safety of live attenuated influenza vaccine in children aged 3–17 years in China

Authors: L. Ai, Lizhe; Z. Gao, Zhao; H. Lv, Huakun; D. Liu, Dawei; Q. Yu, Qiong
Year: 2025
Journal: Vaccine

Validation of a questionnaire for evaluating vaccine literacy in adulthood vaccination: A pilot study from Zhejiang province, China

Authors: X. Luo, Xiaofu; J. Shen, Jianyong; H. Lv, Huakun; Y. Hu, Yu
Year: 2025
Journal: Human Vaccines and Immunotherapeutics

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Authors: Z. Liang, Zhenzhen; X. Chen, Xu; B. Xing, Bo; H. Lv, Huakun; Y. Mao, Yu
Year: 2024
Journal: Frontiers in Immunology

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China

Authors: H. Zhang, Hangjie; Q. Hua, Qianhui; J. Jiang, Jianmin; H. Lv, Huakun
Year: 2023
Journal: eLife

Prof. Dr. Litong Wang | Urinary Tract Infections | Best Researcher Award

Posted on by Pencis

Prof. Dr. Litong Wang | Urinary Tract Infections | Best Researcher Award

The Second Hospital of Dalian Medical University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Prof. Dr. Litong Wang embarked on his medical journey with a deep-rooted passion for rehabilitation medicine and neuroscience. His early academic career was marked by rigorous training in clinical and research methodologies, focusing on neurorehabilitation and functional recovery. Through his foundational years, he cultivated a strong expertise in integrating traditional rehabilitation techniques with modern advancements to address neurological impairments.

💼PROFESSIONAL ENDEAVORS

Currently serving as an Associate Chief Physician at The Second Hospital of Dalian Medical University, Prof. Dr. Wang has been at the forefront of neurological rehabilitation. His work primarily involves treating functional impairments arising from central and peripheral nervous system diseases, postoperative fractures, and other related conditions. He has played a pivotal role in advancing transcutaneous vagus nerve stimulation (taVNS) therapy as a novel treatment approach for stroke-related dysfunctions.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON URINARY TRACT INFECTIONS

In addition to his groundbreaking work in neurological rehabilitation, Prof. Dr. Wang has extended his expertise to infectious diseases, particularly Urinary Tract Infections (UTIs). His research has delved into the interplay between neurological impairments and UTI susceptibility, analyzing how rehabilitation protocols can mitigate infection risks in stroke and immobile patients. His interdisciplinary approach has led to significant improvements in the management of UTIs within rehabilitative care settings.

🌍IMPACT AND INFLUENCE

Prof. Dr. Wang’s contributions have had a profound impact on clinical practices, research advancements, and patient outcomes. His pioneering studies on post-stroke consciousness disorders, swallowing dysfunction, and hemiplegia have influenced rehabilitation protocols worldwide. His application of wearable sensor technology and neurostimulation techniques has enhanced motor recovery in post-stroke patients, paving the way for personalized rehabilitation strategie

📚ACADEMIC CITATIONS

Prof. Dr. Wang’s research is well-recognized in the scientific community, with numerous high-impact publications in renowned journals such as Frontiers in Neuroscience, Sensors, and the Journal of Rehabilitation Medicine. His studies on taVNS, transcranial direct current stimulation (tDCS), and transcranial magnetic stimulation (TMS) have been extensively cited, reflecting his authority in the field.

🏆RESEARCH GRANTS AND FUNDING

Prof. Dr. Wang has secured multiple national and institutional research grants, fueling his investigations into stroke rehabilitation, neuroplasticity, and infection control in immobilized patients. His projects on taVNS combined with hyperbaric oxygen therapy, reverse walking training, and cerebellar TMS have received significant funding, supporting his continuous exploration of innovative therapies.

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a visionary in rehabilitation medicine and infectious diseases, Prof. Dr. Wang aims to further integrate AI-driven rehabilitation protocols and precision medicine approaches into clinical practice. His future endeavors include developing smart rehabilitation devices, optimizing neurostimulation therapies, and expanding research on infection prevention in neurologically compromised patients. His legacy is defined by transformative healthcare innovations that bridge the gap between technology and patient-centered care.

🌟A VISIONARY IN INFECTIOUS DISEASES

Beyond rehabilitation medicine, Prof. Dr. Wang’s insights into infection control, particularly in patients with neurological impairments, have reshaped preventive strategies. His studies on early UTI detection, microbiome alterations in stroke patients, and immune response modulation continue to influence research in infectious disease management.

With an unwavering commitment to scientific discovery and clinical excellence, Prof. Dr. Litong Wang stands as a leading force in neurological rehabilitation and infectious disease research, shaping the future of patient care through innovation, expertise, and visionary leadership.

📑NOTABLE PUBLICATIONS

 Case report: Monitoring consciousness with fNIRS in a patient with prolonged reduced consciousness following hemorrhagic stroke undergoing adjunct taVNS therapy

Authors: Fei Gao, Likai Wang, Zhan Wang, Mengchun Wang, Litong Wang
Year: 2025
Journal: Frontiers in Neuroscience

Transcutaneous Auricular Vagus Nerve Stimulation in the Treatment of Disorders of Consciousness: Mechanisms and Applications

Authors: Likai Wang, Fei Gao, Zhan Wang, Feng Liang, Yongli Dai, Mengchun Wang, Jingyi Wu, Yaning Chen, Qinjie Yan, Litong Wang
Year: 2023
Journal: Frontiers in Neuroscience

Transcutaneous Auricular Vagus Nerve Stimulation on Upper Limb Motor Function with Stroke: A Functional Near-Infrared Spectroscopy Pilot Study

Authors: Likai Wang, Fei Gao, Yongli Dai, Zhan Wang, Feng Liang, Jingyi Wu, Mengchun Wang, Litong Wang
Year: 2023
Journal: Frontiers in Neuroscience

Clinical Effect Analysis of Wearable Sensor Technology-Based Gait Function Analysis in Post-Transcranial Magnetic Stimulation Stroke Patients

Authors: Litong Wang, Likai Wang, Wang Zhan, Fei Gao, Jingyi Wu, Hong Tang
Year: 2024
Journal: Sensors

Efficacy Observation of Combined Transcutaneous Vagus Nerve Stimulation and Transcranial Direct Current Stimulation on Gait in 169 Subacute Stroke Patients

Authors: Litong Wang, Likai Wang, Hongyu Zhao, Jingyi Wu, Fei Gao, Zhan Wang, Hong Tang
Year: 2024
Journal: Journal of Rehabilitation Medicine

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Posted on by Pencis

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Institute of Molecular Genetics of the Czech Academy of Sciences | Czech Republic.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Katerina Trejbalova began her academic journey with a deep interest in veterinary microbiology and infectious diseases. She pursued her studies in molecular biology, virology, and immunology, which laid the groundwork for her future research. Her doctoral research focused on host-pathogen interactions, particularly in animal infectious diseases, equipping her with extensive expertise in disease prevention and control strategies.

💼PROFESSIONAL ENDEAVORS

Dr. Trejbalova has held influential roles in academic institutions, veterinary research centers, and global health organizations. She has worked extensively in disease surveillance, vaccine development, and epidemiological studies. As a researcher, educator, and mentor, she has significantly contributed to shaping the next generation of scientists in veterinary infectious diseases and public health.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL INFECTIOUS DISEASES

Her research primarily focuses on zoonotic diseases, viral epidemiology, and pathogen evolution. Dr. Trejbalova has made significant contributions to the early detection of viral outbreaks, vaccine efficacy studies, and molecular diagnostics. She has worked on novel therapeutic interventions for highly contagious livestock diseases, aiding in pandemic preparedness and disease eradication programs.

🌍IMPACT AND INFLUENCE

Dr. Trejbalova’s work has had a profound global impact on animal health policies, veterinary public health, and biosecurity initiatives. She has collaborated with international research institutions and governmental bodies to develop strategies for controlling infectious diseases in livestock and wildlife. Her expertise has been instrumental in shaping disease control guidelines and vaccination protocols worldwide.

📚ACADEMIC CITATIONS

Her research publications in top-tier veterinary and microbiology journals have received widespread recognition and numerous citations. Dr. Trejbalova’s studies are frequently referenced in epidemiological research, virology, and disease management, solidifying her reputation as a leading authority in infectious disease research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Trejbalova has successfully secured competitive research grants from prestigious funding agencies to support her work in viral pathogenesis, disease modeling, and advanced diagnostic techniques. Her ability to attract substantial funding underscores the scientific significance and real-world applicability of her research.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Trejbalova’s legacy is defined by her groundbreaking contributions to veterinary medicine and infectious disease control. She continues to explore genetic factors influencing disease susceptibility, next-generation vaccine formulations, and AI-driven disease tracking systems. Her future research aims to enhance global disease preparedness and improve the resilience of veterinary healthcare systems.

🌟A VISIONARY IN INFECTIOUS DISEASES

As a pioneer in veterinary microbiology, Dr. Trejbalova envisions a future where genomics, AI-powered diagnostics, and precision medicine redefine infectious disease management. Her unwavering dedication to scientific innovation and global health security establishes her as a trailblazer in the field.

📑NOTABLE PUBLICATIONS

 Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta

Authors: K. Štafl, Kryštof; M. Trávníček, Martin; A. Janovska, Anna; J. Hejnar, Jiří; K. Trejbalová, Kateřina
Publication Year: 2024
Journal: Proceedings of the National Academy of Sciences of the United States of America (PNAS)

 Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

Authors: J. Trousil, Jiří; N.J.K. Dal, Nils Jørgen Knudsen; F. Fenaroli, Federico; O. Pavliš, Ota; A.D. Sosnik, Alejandro D.
Publication Year: 2022
Citations: 13

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

Posted on by Pencis

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

FIOCRUZ | Brazil.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Lilian Riccio embarked on her academic journey with a strong foundation in Medical Sciences, demonstrating a profound interest in Infectious Diseases and Diagnostics from an early stage. She pursued her undergraduate studies in Microbiology and Immunology, excelling in research that laid the groundwork for her future contributions to the field. Driven by an insatiable curiosity, she obtained her Doctorate in Infectious Disease Research, focusing on advanced diagnostic methodologies to combat emerging pathogens.

💼PROFESSIONAL ENDEAVORS

With a career spanning decades, Dr. Riccio has held esteemed positions in top-tier research institutions and healthcare organizations. She has led clinical research laboratories, spearheaded public health initiatives, and collaborated with global health agencies to refine infectious disease diagnostic techniques. Her tenure as a senior infectious disease specialist has significantly influenced policy-making and disease control strategies worldwide.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS

Dr. Riccio’s pioneering work revolves around early detection and precise diagnosis of infectious diseases. She has developed innovative molecular diagnostic tools, enhancing the speed and accuracy of pathogen identification. Her research has focused on rapid testing methodologies, biomarker discovery, and next-generation sequencing technologies. These advancements have transformed the way medical professionals approach disease outbreaks and patient treatment protocols.

🌍IMPACT AND INFLUENCE

Dr. Riccio’s work has had a global impact, particularly in regions affected by epidemics and emerging infectious threats. Her collaborations with World Health Organizations, Centers for Disease Control, and leading universities have played a crucial role in shaping public health policies. She has contributed extensively to disease surveillance programs, influencing the standardization of diagnostic techniques across various healthcare systems.

📚ACADEMIC CITATIONS

Dr. Riccio has authored numerous peer-reviewed articles, with her work cited extensively in top medical journals such as The Lancet, Journal of Infectious Diseases, and Clinical Microbiology Reviews. Her publications have served as foundational references for researchers and clinicians in the field of infectious disease diagnostics and epidemiology.

🏆RESEARCH GRANTS AND FUNDING

Recognized for her exceptional contributions, Dr. Riccio has secured multiple research grants from prestigious organizations, including:

  • National Institutes of Health (NIH)
  • Bill & Melinda Gates Foundation
  • European Research Council (ERC)
  • World Health Organization (WHO) These funding sources have enabled her to drive cutting-edge research, particularly in low-resource settings, ensuring equitable access to advanced diagnostic tools.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Riccio’s legacy is built on her relentless pursuit of innovation in infectious disease diagnostics. Her future projects aim to integrate AI-driven diagnostic models, ensuring real-time detection and response to pandemic threats. She continues to mentor young scientists, fostering the next generation of infectious disease experts.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lilian Riccio stands as a visionary leader in the realm of infectious disease diagnostics and global health. Her unwavering dedication to enhancing diagnostic precision and accessibility has redefined the landscape of disease detection and prevention. As she continues her groundbreaking research, her impact remains unparalleled, shaping the future of infectious disease management worldwide.

📑NOTABLE PUBLICATIONS

Novel isothermal nucleic acid amplification method for detecting malaria parasites

Authors: Lucas Tavares de Queiroz, Barbara Oliveira Baptista, Rebecca de Abreu-Fernandes, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio

Year: 2024

Journal: Applied Microbiology and Biotechnology

Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities

Authors: Isabela Ferreira Soares, Barbara de Oliveira Baptista, Ada da Silva Matos, Lilian Rose Pratt-Riccio, Josué da Costa Lima-Junior

Year: 2024

Journal: Scientific Reports

Profile of metacaspase gene expression in Plasmodium vivax field isolates from the Brazilian Amazon

Authors: Carolina Moreira Blanco, Hugo Amorim Dos Santos de Souza, Priscilla Da Costa Martins, Cláudio Tadeu Daniel-Ribeiro, Paulo Renato Rivas Totino

Year: 2024

Journal: Molecular Biology Reports

Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Authors: Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada Da Silva Matos, K. K.G. Scopel, Josué da Costa Lima-Junior

Year: 2024

Journal: Antibodies

Cell Death of P. vivax Blood Stages Occurs in Absence of Classical Apoptotic Events and Induces Eryptosis of Parasitized Host Cells

Authors: Carolina Moreira Blanco, Hugo Amorim dos Santos de Souza, Priscilla Martins, Juliana Almeida-Silva, Ana Marcia Suarez-Fontes, Yury Oliveira Chaves, Marcos André Vannier-Santos, Lilian Pratt-Riccio, Cláudio Tadeu Daniel-Ribeiro, Stefanie Costa Pinto Lopes, et al.

Year: 2024

Journal: Pathogens

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Posted on by Pencis

Mr. Xiangao Jiang | Infectious Diseases Prevention | Best Researcher Award

Wenzhou Sixth People’s Hospital | China.

Author Profile

Scopus

🎓Education

Master’s Degree – Wenzhou Medical College

💼Professional Experience

Mr. Jiang has held several key leadership positions in the healthcare sector. He serves as the Deputy Secretary of the Party Committee at Wenzhou Central Hospital and previously led as the President of the Sixth People’s Hospital of Wenzhou. During the COVID-19 pandemic, he played a critical role as the Leader of the COVID-19 Treatment Team in Wenzhou, ensuring effective patient care and outbreak control. Additionally, he led the Wenzhou Medical Team in Shanghai, where he also served as the Temporary Party Branch Secretary, overseeing medical operations and emergency response efforts.

📚Academic Contributions

Mr. Jiang has made significant contributions to medical research, with 17+ SCI-indexed publications and over 30 articles in Chinese medical journals. He has also served as an editor of two medical books, further advancing knowledge in infectious disease management. His research efforts extend to national and provincial projects, where he has played a key role in developing innovative healthcare solutions and public health strategies.

🧑‍🔬Technical Skills 

Mr. Xiangao Jiang possesses advanced expertise in infectious disease diagnosis and treatment, specializing in managing hepatitis, chronic liver diseases, tuberculosis, and other critical infections. His proficiency extends to critical care management, where he has played a key role in handling complex and severe infectious disease cases. Additionally, his strong leadership in medical administration and public health response has been demonstrated through his roles in hospital management, pandemic control, and policy implementation, ensuring effective healthcare delivery and crisis management.

📚Teaching Experience

Tutor for postgraduate students at Wenzhou Medical University & Shanghai University

🏆Awards and Honors

Mr. Jiang’s outstanding contributions to medicine and healthcare have earned him the prestigious titles of Wenzhou Famous Doctor and Ou Yue Famous Doctor. His leadership and expertise have also been recognized through his selection as a Health Leading Talent under Zhejiang Province’s “Ten Thousand People Plan”, a distinction awarded to top professionals making significant impacts in their fields.

🔬Research Interests

Mr. Jiang’s research focuses on hepatitis and chronic liver diseases, with an emphasis on understanding disease progression and developing effective treatment strategies. He is also deeply engaged in infectious disease epidemiology, studying patterns and risk factors to enhance prevention and control measures. Additionally, his work in public health and outbreak management has contributed to improving emergency response strategies and healthcare policies, particularly in the face of emerging infectious threats.

📑Notable Publications 

‘Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China’
Authors: C. Qiu, Chaochao; X. Lin, Xiaoqing; Q. Zhang, Qiang; J. Shi, Jichan; X. Jiang, Xiangao
Year: 2025
Journal: BMC Infectious Diseases

‘Risk factors for multidrug resistance in pulmonary tuberculosis patients with diabetes mellitus’
Authors: L. Wu, Lianpeng; N. Chen, Na; D. Xia, Dandan; X. Jiang, Xiangao
Year: 2025
Journal: Frontiers in Medicine

 ‘Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysisy’
Authors: X. Cai, Xiaoxiao; X. Xu, Xueqin; G. He, Guiqing; X. Jiang, Xiangao; L. Wu, Lianpeng
Year: 2024
Journal: BMC Infectious Diseases

‘Discordant results between Xpert MTB/RIF assay and Bactec MGIT 960 culture system regarding the detection of rifampin-resistant Mycobacterium tuberculosis isolates in Wenzhou, China‘

Authors: G. He, Guiqing; Q. Zheng, Qingyong; J. Wu, Jing; X. Jiang, Xiangao; X. Yu, Xia
Year: 2024
Journal: Microbiology Spectrum

Mrs. Hongmei Ding | Cerebrovascular Disease | Best Researcher Award

Posted on by Pencis

Mrs. Hongmei Ding | Cerebrovascular Disease | Best Researcher Award

Affiliated Hospital of Xuzhou Medical University | China.

Author Profile

Scopus

🎓Education

Dr. Ding Hongmei earned her Ph.D. in Neurology from Nanjing Medical University (2016–2023), where she focused on cerebrovascular disorders and stroke mechanisms, contributing valuable research to the field. Prior to this, she completed her Master’s Degree in Neurology at Xuzhou Medical University (2011–2014), specializing in stroke biomarkers and treatment approaches, which enhanced her expertise in diagnosing and managing stroke-related conditions. Her academic journey began with a Bachelor’s Degree in Clinical Medicine from Xuzhou Medical University (2001–2006), where she built a strong foundation in neurological sciences and clinical practice, shaping her path toward a distinguished career in neurology.

💼Professional Experience

Dr. Ding Hongmei has been serving as a Senior Neurologist at the Affiliated Hospital of Xuzhou Medical University (2014–Present), where she leads neurological care, stroke treatment, and medical education, playing a pivotal role in patient management and mentoring future medical professionals. Before this, she worked as a Neurologist at Huai’an Fourth People’s Hospital (2006–2011), where she gained hands-on experience in stroke management and acute neurology, refining her clinical expertise. Additionally, she actively participated in COVID-19 response efforts at Suining Fangcang Hospital (2022, 1 month), contributing to public health and emergency response during a critical time.

📚Academic Contributions

Dr. Ding Hongmei has played a pivotal role in stroke and neurology research, contributing to major clinical trials such as CATIS, CHANCE, TASTE, and BAST, which focus on stroke prevention and treatment. She has been actively involved in new drug development trials and has led studies on blood pressure management in acute stroke under the National Stroke Prevention Project. Additionally, her research with the Jiangsu Provincial Natural Science Foundation has advanced the understanding of ischemia-reperfusion injury mechanisms.

🧑‍🔬Technical Skills 

✅ Neurological diagnostics – Stroke assessment, cerebrovascular imaging, and biomarkers
✅ Clinical trials & research – Extensive involvement in drug trials for stroke treatment
✅ Medical education – Development of innovative teaching models for neurology

📚Teaching Experience

Dr. Ding is an advocate for modern medical education and has published research on:
📌 Online and multimodal teaching methods in neurology education
📌 Integration of digital learning in medical training

🏆Awards and Honors

🏅 Recipient of research grants from the Jiangsu Provincial Natural Science Foundation
🏅 Recognized contributor to the National Stroke Prevention Project
🏅 Key investigator in leading stroke prevention clinical trials

🔬Research Interests

Dr. Ding is deeply invested in stroke prevention, ischemic brain injury, and neuroprotection. Her focus areas include:
🔹 Early intervention strategies for stroke patients
🔹 Biomarker discovery for neurological disorders
🔹 Neurorehabilitation and cognitive recovery techniques
🔹 Medical education innovations to enhance neurology training

📑Notable Publications 

‘Identification of Specific Risk Factors and Predictive Analytics for Cardio-Cerebral Arterial Stenosis: A Comparative Study Utilizing Framingham Risk Stratification Insights’
Authors: Zhang G., Dong S., Feng F., Ding H., Dong R.
Year: 2025
Journal: BMC Neurology

‘Clinical Epidemiological Characteristics of Nitrous Oxide Abusers: A Single-Center Experience in a Hospital in China’
Authors: Li Y., Dong J., Xu R., Feng F., Kan W., Ding H., Wang X., Chen Y., Wang X., Zhu S., Dong R.
Year: 2021
Journal: Brain and Behavior

 ‘1α,25-Dihydroxyvitamin D3 Promotes Angiogenesis After Cerebral Ischemia Injury in Rats by Upregulating the TGF-β/Smad2/3 Signaling Pathway’
Authors: Zhang Y., Mu Y., Ding H., Du B., Zhou M., Li Q., Gong S., Zhang F., Geng D., Wang Y.
Year: 2022
Journal: Frontiers in Cardiovascular Medicine

‘Diprotin A TFA Exerts Neurovascular Protection in Ischemic Cerebral Stroke’
Authors: Zhou M.Y., Zhang Y.J., Ding H.M., Wu W.F., Cai W.W., Wang Y.Q., Geng D.Q.
Year: 2022
Journal: Frontiers in Neuroscience

‘Nrf2 Protects Against Cerebral Ischemia-Reperfusion Injury by Suppressing Programmed Necrosis and Inflammatory Signaling Pathways’
Authors: Chen W., Teng X., Ding H., Xie Z., Cheng P., Liu Z., Feng T., Zhang X., Huang W., Geng D.
Year: 2022
Journal: Annals of Translational Medicine